"Clinical Research Site for orthopedics and pain management clinical trials."

During the past decade, Georgia Institute for Clinical Research, LLC conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 21 clinical trials were completed, i.e. on average, 140% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 9 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Georgia Institute for Clinical Research, LLC" #1 sponsor was "Purdue Pharma LP" with 7 trials, followed by "Pfizer" with 3 trials sponsored, "BioDelivery Sciences International" with 2 trials sponsored, "Centrexion Therapeutics" with 2 trials sponsored and "Cephalon" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Georgia Institute for Clinical Research, LLC" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Ferring Pharmaceuticals" with 1 trials as a collaborator, "Quintiles, Inc." with 1 trials as a collaborator and "Teva Pharmaceutical Industries, Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Georgia Institute for Clinical Research, LLC" are "Low Back Pain" (6 trials), "Chronic Pain" (4 trials), "Back Pain Lower Back Chronic" (3 trials), "Chronic Low Back Pain" (3 trials) and "Osteoarthritis" (3 trials). Many other conditions were trialed in "Georgia Institute for Clinical Research, LLC" in a lesser frequency.

Most popular intervention types in "Georgia Institute for Clinical Research, LLC" are "Drug" (33 trials), "Device" (4 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Buprenorphine" (4 trials), "Adipose Derived Regenerative Cells" (2 trials), "Buprenorphine transdermal patch" (2 trials) and "CNTX-4975-05" (2 trials). Other intervention names were less common.

The vast majority of trials in "Georgia Institute for Clinical Research, LLC" are 36 trials for "All" genders.

Currently, there are NaN active trials in "Georgia Institute for Clinical Research, LLC". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 28 completed trials in Georgia Institute for Clinical Research, LLC, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Georgia Institute for Clinical Research, LLC, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".